- Home
- BFC vs TSHA Comparison
BFC vs TSHA Comparison
Compare BFC & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BFC | TSHA |
|---|---|---|
| Founded | 1894 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | BFC | TSHA |
|---|---|---|
| Price | $130.67 | $5.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $142.00 | $10.22 |
| AVG Volume (30 Days) | 56.5K | ★ 3.5M |
| Earning Date | 01-20-2026 | 11-04-2025 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.11 | N/A |
| Revenue | ★ $168,778,000.00 | $6,310,000.00 |
| Revenue This Year | $11.79 | N/A |
| Revenue Next Year | $32.03 | N/A |
| P/E Ratio | $18.33 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $92.49 | $1.05 |
| 52 Week High | $135.72 | $5.51 |
Technical Indicators
Market Signals| Indicator | BFC | TSHA |
|---|---|---|
| Relative Strength Index (RSI) | 59.91 | 60.49 |
| Support Level | $122.95 | $4.03 |
| Resistance Level | $127.78 | $4.92 |
| Average True Range (ATR) | 3.65 | 0.29 |
| MACD | 0.93 | 0.08 |
| Stochastic Oscillator | 88.71 | 84.91 |
Price Performance
Historical ComparisonAbout BFC Bank First Corporation
Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.